2007Zhongguo xunhuan zazhiRequires access

Relationship Between Apolipoprotein A5-1131T>C Polymorphism and Coronary Heart Disease

Nie Sa

Open publisher page 3 citations

Abstract

Objective:To investigate the correlation between apolipoprotein (APO) A5-1131TC polymorphism and coronary heart disease (CHD). Methods: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and polyacrylamide gel eletro-phoresis (PAGE) were used to analyze genotypic polymorphism in 186 patients with CHD and 268 healthy controls. The levels of serum lipid profiles were also measured by enzymatic methods. Results:The APOA5-1131T C genotype distribution in CHD group and the control group showed a significant difference. The frequency of the -1131C allele in patients with CHD was significantly higher than that of the controls (0.422 vs. 0. 321 ,P0.05). The serum TG levels among three genotype groups showed a significant difference. The TG levels in type TC( 1. 50±0.78 mmol/L) and type CC( 1.73±1.22 mmol/L)were significantly higher than in type TT(1. 29±0. 74 mmol/L) (all P0.05), but there was no significant difference between type TC and type CC(P0.05). Compared with noncarriers (type TC +CC), C carriers (type TT) also had a higher TG levels in CHD group (1.46±0. 86 mmol/L vs 1. 73±0. 95 mmol/L, P 0. 05). The levels of TC, HDL-C and LDL-C showed no statistical differences between various genotypes (P 0.05). Unadjusted logistic regression analysis indicated that TC + CC genotype of A5-1131TC had an increased CHD risk (OR = 1. 520,95% CI 1. 044-2. 215,P =0. 029). But the analysis did not show that TC + CC genotype was independently associated with an increased risk of CHD (OR = 1. 331,95% CI 0. 634-2. 794, P= 0.449) after adjusted for BMI, presence of hypertension or diabetes and HDL-C levels. Conclusion; The frequency of APOA5-1131C allele in patients with CHD was significantly higher than that of the healthy individuals. The APOA5-1131T C variant was significantly associated with increased serum TG levels. The APOA5-1131T C variant may be associated with an increased risk of CHD. However, as an independent risk factor for CHD needs further study.

About this research paper

What this paper is about

Objective:To investigate the correlation between apolipoprotein (APO) A5-1131TC polymorphism and coronary heart disease (CHD). Methods: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and polyacrylamide gel eletro-phoresis (PAGE) were used to analyze genotypic polymorphism in 186 patients with CHD and 268 healthy controls. The levels of serum lipid profiles were also measured by enzymatic methods. Results:The APOA5-1131T C genotype distribution in CHD group and the control group showed a significant difference. The frequency of the -1131C allele in patients with CHD was significantly higher than that of the controls (0.422 vs. 0. 321 ,P0.05). The serum TG levels among three genotype groups showed a significant difference. The TG levels in type TC( 1. 50±0.78 mmol/L) and type CC( 1.73±1.22 mmol/L)were significantly higher than in type TT(1. 29±0. 74 mmol/L) (all P0.05), but there was no significant difference between type TC and type CC(P0.05). Compared with noncarriers (type TC +CC), C carriers (type TT) also had a higher TG levels in CHD group (1.46±0. 86 mmol/L vs 1. 73±0. 95 mmol/L, P 0. 05). The levels of TC, HDL-C and LDL-C showed no statistical differences between various genotypes (P 0.05). Unadjusted logistic regression analysis indicated that TC + CC genotype of A5-1131TC had an increased CHD risk (OR = 1. 520,95% CI 1. 044-2. 215,P =0. 029). But the analysis did not show that TC + CC genotype was independently associated with an increased risk of CHD (OR = 1. 331,95% CI 0. 634-2. 794, P= 0.449) after adjusted for BMI, presence of hypertension or diabetes and HDL-C levels. Conclusion; The frequency of APOA5-1131C allele in patients with CHD was significantly higher than that of the healthy individuals. The APOA5-1131T C variant was significantly associated with increased serum TG levels. The APOA5-1131T C variant may be associated with an increased risk of CHD. However, as an independent risk factor for CHD needs further study.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the correlation between apolipoprotein (APO) A5-1131TC polymorphism and coronary heart disease (CHD). Methods: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and polyacrylamide gel eletro-phoresis (PAGE) were used to analyze genotypic polymorphism in 186 patients with CHD and 268 healthy controls. The levels of serum lipid profiles were also measured by enzymatic methods. Results:The APOA5-1131T C genotype distribution in CHD group and the control group showed a significant difference. The frequency of the -1131C allele in patients with CHD was significantly higher than that of the controls (0.422 vs. 0. 321 ,P0.05). The serum TG levels among three genotype groups showed a significant difference. The TG levels in type TC( 1. 50±0.78 mmol/L) and type CC( 1.73±1.22 mmol/L)were significantly higher than in type TT(1. 29±0. 74 mmol/L) (all P0.05), but there was no significant difference between type TC and type CC(P0.05). Compared with noncarriers (type TC +CC), C carriers (type TT) also had a higher TG levels in CHD group (1.46±0. 86 mmol/L vs 1. 73±0. 95 mmol/L, P 0. 05). The levels of TC, HDL-C and LDL-C showed no statistical differences between various genotypes (P 0.05). Unadjusted logistic regression analysis indicated that TC + CC genotype of A5-1131TC had an increased CHD risk (OR = 1. 520,95% CI 1. 044-2. 215,P =0. 029). But the analysis did not show that TC + CC genotype was independently associated with an increased risk of CHD (OR = 1. 331,95% CI 0. 634-2. 794, P= 0.449) after adjusted for BMI, presence of hypertension or diabetes and HDL-C levels. Conclusion; The frequency of APOA5-1131C allele in patients with CHD was significantly higher than that of the healthy individuals. The APOA5-1131T C variant was significantly associated with increased serum TG levels. The APOA5-1131T C variant may be associated with an increased risk of CHD. However, as an independent risk factor for CHD needs further study.

Key concepts: Genotype, Internal medicine, Medicine, Coronary heart disease, Gastroenterology, Apolipoprotein B, Polymorphism (computer science), Logistic regression

Related papers

Back to paper searchBrowse research topicsOriginal source
Relationship Between Apolipoprotein A5-1131T>C Polymorphism and Coronary Heart Disease — Research Paper | ScholarLens